Richard Furman
Overview
Explore the profile of Richard Furman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
1095
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bustoros M, Gribbin C, Castillo J, Furman R
Hematol Oncol Clin North Am
. 2023 Aug;
37(4S):e1-e13.
PMID: 37574332
Waldenström macroglobulinemia is an indolent IgM-secreting B-cell lymphoplasmacytic lymphoma that is preceded by an asymptomatic stage. Clinical and molecular features have been used in risk models to predict progression rates...
2.
Thompson M, Harrup R, Coombs C, Roeker L, Pu J, Choi M, et al.
Blood Adv
. 2022 Jun;
6(15):4553-4557.
PMID: 35736670
No abstract available.
3.
Jurgens E, Ketas T, Zhao Z, Joseph Satlin M, Small C, Sukhu A, et al.
Am J Hematol
. 2021 Aug;
96(11):E410-E413.
PMID: 34390501
No abstract available.
4.
Orfali N, Jhanwar Y, Koo C, Pasciolla M, Baldo M, Cuvilly E, et al.
Leuk Lymphoma
. 2021 Feb;
62(7):1629-1638.
PMID: 33586581
We evaluate the safety of bendamustine as a bridge to stem cell transplantation (SCT) in patients with relapsed/refractory lymphoma and residual disease after salvage therapy. Thirty-four subjects without complete responses...
5.
Brown J, Zelenetz A, Furman R, Lamanna N, Mato A, Montillo M, et al.
Leukemia
. 2020 Jul;
34(12):3404-3407.
PMID: 32655145
No abstract available.
6.
Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, et al.
Leuk Lymphoma
. 2019 May;
60(12):2917-2921.
PMID: 31120355
In mantle cell lymphoma (MCL), cyclin D1 combines with CDK4/6 to phosphorylate Rb, releasing a break on the G1 to S phase cell cycle. Palbociclib is a specific, potent, oral...
7.
Gaiti F, Chaligne R, Gu H, Brand R, Kothen-Hill S, Schulman R, et al.
Nature
. 2019 May;
569(7757):576-580.
PMID: 31092926
Genetic and epigenetic intra-tumoral heterogeneity cooperate to shape the evolutionary course of cancer. Chronic lymphocytic leukaemia (CLL) is a highly informative model for cancer evolution as it undergoes substantial genetic...
8.
Paulus A, Manna A, Akhtar S, Paulus S, Sharma M, Coignet M, et al.
Br J Haematol
. 2018 Aug;
183(2):196-211.
PMID: 30080238
CD38 is expressed on Waldenström macroglobulinaemia (WM) cells, but its role as a therapeutic target remains undefined. With recent approval of the anti-CD38 monoclonal antibody, daratumumab (Dara), we hypothesized that...
9.
Pera B, Tang T, Marullo R, Yang S, Ahn H, Patel J, et al.
Clin Epigenetics
. 2016 Jul;
8:79.
PMID: 27453763
Background: Refractory and/or relapsed diffuse large B cell lymphoma (RR-DLBCL) patients are incurable with conventional chemotherapy due to the aggressiveness and the chemorefractory state of these tumors. DNA hypermethylation and...
10.
Reiss J, Link B, Ruan J, Furman R, Coleman M, Leonard J, et al.
Leuk Lymphoma
. 2015 Feb;
56(10):2870-5.
PMID: 25676037
Existing data suggest that myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) peak in incidence 5-10 years following exposure to ionizing radiation, while most publications report less than 5 years...